Authors/Disclosures
|
|
No disclosure on file |
|
Jose Luiz Pedroso, MD
(Universidade Federal De Sao Paulo)
|
Dr. Pedroso has nothing to disclose. |
|
Pedro Braga-Neto, MD, PhD
(Universidade Federal Do Ceara)
|
Dr. Braga-Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Braga-Neto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Maria-Luiza Saraiva-Pereira
(Universidade Federal Do Rio Grande Do Sul)
|
No disclosure on file |
|
Richard S. Finkel, MD, FAAN
(St. Jude Children's Research Hospital)
|
Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities. |
|
Laura Jardim
|
No disclosure on file |
|
Orlando G. Barsottini, MD, PhD
(Universidade Federal de São Paulo)
|
Dr. Barsottini has nothing to disclose. |
|
Eugene Schneider, MD
(Ionis Pharmaceuticals, Inc)
|
Dr. Schneider has received personal compensation for serving as an employee of ionis pharmaceuticals. |
|
|
No disclosure on file |
|
Pedro G. Nofal, MD
|
No disclosure on file |